School-Based Interventions for Anxiety in Autism
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to compare two school based interventions to manage anxiety in autistic students. The main question\[s\] it aims to answer are: 1) Compare the effectiveness of Facing Your Fears-School Based Program (FYF-SB) with Zones of Regulation (ZOR) on anxiety reduction and emotion regulation; and 2) examine the feasibility and satisfaction of FYF-SB and ZOR, according to students, caregivers and school providers. Autistic students with anxiety between 8-14 years will be randomized to either FYF-SB and ZOR. They will participate in one of the programs for 12 weeks and pre, post and follow-up measures will occur.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Facing Your Fears - School Based for anxiety in autism?
Research shows that the Facing Your Fears - School Based treatment helps reduce anxiety in autistic students, with significant improvements reported in school settings. The program is adaptable, easy to use by school staff, and has been effective in both the US and Singapore, with many students experiencing meaningful reductions in anxiety.12345
Is the school-based Facing Your Fears program safe for autistic students with anxiety?
How is the treatment 'Facing Your Fears - School Based' different from other treatments for anxiety in autism?
Facing Your Fears - School Based is unique because it adapts cognitive behavioral therapy (CBT) for delivery in school settings, making it accessible to autistic students who might not otherwise receive such treatment. It is designed to be flexible and easy for various school providers to use, even those without a mental health background, which helps in reaching a broader range of students.12467
Research Team
Judy Reaven, Ph.D.
Principal Investigator
University of Colorado, Denver
Eligibility Criteria
This trial is for autistic students aged 8-14 who experience anxiety and have a medical or educational diagnosis of ASD, or suspected ASD. They must also show significant social challenges as measured by the SRS-2. It's not suitable for those outside this age range or without these specific needs.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either the Facing Your Fears-School Based Program (FYF-SB) or Zones of Regulation (ZOR) for 12 weeks
Post-Intervention Assessment
Assessments conducted to evaluate the effectiveness of the interventions
Follow-up
Participants are monitored for long-term outcomes and effectiveness of the interventions
Treatment Details
Interventions
- Facing Your Fears - School Based (Behavioral Intervention)
- Zones of Regulation (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
Aviva Abosch
University of Colorado, Denver
Chief Medical Officer since 2019
MD
Uday B. Kompella
University of Colorado, Denver
Chief Executive Officer since 2015
PhD in Pharmaceutical Sciences
Emory University
Collaborator
Dr. R. Donald Harvey
Emory University
Chief Medical Officer
MD from Emory University School of Medicine
Dr. George Painter
Emory University
Chief Executive Officer since 2013
PhD in Synthetic Organic Chemistry from Emory University
Patient-Centered Outcomes Research Institute
Collaborator
Nakela L. Cook
Patient-Centered Outcomes Research Institute
Chief Executive Officer since 2020
MD, MPH
Harv Feldman
Patient-Centered Outcomes Research Institute
Chief Medical Officer
MD, MSCE
University of North Carolina, Chapel Hill
Collaborator
Dr. Peggy P. McNaull
University of North Carolina, Chapel Hill
Chief Medical Officer
MD from Louisiana State University School of Medicine
Dr. Lynne Fiscus
University of North Carolina, Chapel Hill
Chief Executive Officer since 2020
MD from Georgetown University, MPH from UNC